FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said

FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said
FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said submitted by /u/shallah
[link] [comments]
https://ift.tt/3BKcUb7 November 03, 2021 at 10:28AM https://ift.tt/1R552o9

No comments:

Post a Comment